PVR: 1599: Sales growth LT: 28 CY: 702 9M RESULT UPDATE ON 4TH FEB-22 | Profit From It
📢 5 STEPS TOWARDS WEALTH 🚀 The Indian Stock Market Way
📢 5 STEPS TOWARDS WEALTH 🚀 The Indian Stock Market Way
📍 Delhi | 22nd March 2025 | Saturday / 🕕 5:59 PM - 9:01 PM (Entry from 5:30 PM onwards)
REGISTER NOW
1800 890 4317
profitfromit1@gmail.com

PVR: 1599: Sales growth LT: 28 CY: 702 9M RESULT UPDATE ON 4TH FEB-22

Lesson 186/223 | Study Time: 5 Min

PVR: 9M: PUSHPA GIVES A GOOD JUMP IN FOOTFALLS & PVR DELIVERS THE SAME DIALOGUE: MAIN JHUKEGA NAHI!


One of the largest players in the specialty retail industry. PVR is a Film entertainment company in India. PVR Ltd was incorporated IN 1995, as Priya Village Roadshow Ltd pursuant to a joint venture agreement between Priya Exhibitors Pvt Ltd and Village Roadshow Ltd. Later ICICI Venture invested around 40 Cr in 2003. 


Very high growth has been seen during the last decade as the revenue has risen from 50 Cr during the year 2003 to 3400 Cr Pre-Covid shows the CAGR growth of 28%. Located at around 179 locations, 73 Cities have 860 Screens with a 1.82 Lakh Seating Capacity. Yes, there was some debt along with high lease cost, hence have small historical margins of around 4-5%. But they are the leaders and with better margins then other peers. Sales growth of 28%, while due to low margins Profits have grown by 12% & price has appreciated by 15% CAGR along with Consistent Dividends. High growth has given good profit to investors as an investment is 6X in the last 13 years of IPO. So yes considering a company from the emerging industry of India but with debt & large rental lease liability as -ve point 1% investment of the portfolio has been recommended for a long time by us. Many people have already held since 6 years back around 300 and are still holding even during this challenging time...why?


Specialty retail and majorly touch intensive industry like multiplex was the most affected industry during Covid. The history of continuous growth was broken during covid as this 2021 was the 1st year in their history since IPO where we saw the sales in de-growth, this is the effect of the pandemic. The effect was not short-lived but it hurt the footfalls and the sales were damaged by 92% last year. 90% of the industries were able to recover but this industry was highly touched intensive and hence the damage was not recovered. Single year loss last year of 750 Cr was equal to full compounded 17 years profit of 750 cr. A huge problem we saw here. Management were able to infuse more capital and even the landowner helped them with rentals refund which helped the company during covid. 


The entire circuit had become operational in Q3 this year with Maharashtra allowing cinemas to commence operations from October onwards. Content flow from the Bollywood film industry commenced post-Maharashtra re-opening, resulting in business witnessing robust demand in the months of November and December this year. The Q3 was marked with strong performances from movies such as Sooryavanshi, Annaatthe, Eternals (during November’21), Spiderman, 83, & best of all Pushpa delivering excellent box office collections. The business at least stopped burning cash after
the long 6 quarters. Telangana, AP and MP are running at 100% capacity, while Maharashtra, Karnataka, UP, TN, Gujarat & Punjab running at 50% capacity. We saw the net sales growth of 702% this 9M due to low base and highly affected last year. Even waiver from landlord this 9M of 284 Cr also helped in other income. BROADBASED DEMAND RECOVERY ON THE BACK OF NEW CONTENT was seen. During Oct we saw 39% footfalls, Novemeber was with 58% recovery in footfalls while December was with 77% recovery as during this time Pushpa and Spiderman gave huge spike of 112% recovery in footfalls even if we consider pre-covid era. That shows the huge recovery and even it shows a bright future ahead. East and South are already showing more than 100% footfalls precovid.  Q3 FY 22 was the best quarter in the last 7 quarters with the Bollywood movie release calendar starting in Nov’21. There was an improvement in operating performance driven by strong growth in Admits 191 lakh v/s just 10 lakh last year, Average Ticket Price of 229 v/s 166 last year. It resulted in a much stronger revenue recovery. Sales in movie tickets along with Food & Beverages also helped as it grew from 243 Cr v/s 191 Cr last year. Wave 2 rental negotiations have been concluded for >97% of properties. Achieved rental discount of 57% in 9M FY 22. Fresh discussions are underway for the current ongoing wave of Covid.

Hence pure sales growth of 702% was seen and even expected 500% growth this year which will take PVR towards the sales of 1700 Cr this year which is still lesser than provide the level of 3400 cr. We may see PVR cross pre-covid level next Year. Losses are also improving by improved margins, we saw growth of 17% this 9M. This year we may see PVR with the loss of 500-600 Cr which is still better than last year's 750Cr. Profits should be back in 2023. The debt of 1500 Cr is a high debt v/s total equity of 1800 Cr, but this is a challenging time for the whole industry. 


STRONG LINE UP OF MOVIES this year like, GANGUBAI KATHIAWADI, JAYESHBHAI JORDAAR, BACHCHAN PANDEY, DHAAKAD, LAAL SINGH CHADDHA, TIGER 3, MAIDAAN, RAKSHA BANDHAN, THE KASHMIR FILES, PRITHVIRAJ, JHUND and many more. 


All those added during these bad times and fall near 1000 should hold it and again new buying can be done during any fall in the whole range of 1350 to 900 and can book some 5%-10% Profits during recovery near 1920 this year. Can expect 15-20% growth in the future and a multi-year rally could be seen with near-term strong challenges due to the increasing debt burden in the Covid era. 1% weightage of Portfolio should be tied up. Good for long term, but 2 Years could be affected till again we see the normalcy. 


Just 17% promoter holding while 17% MF companies holding and 43% FII holding. ICICI PRU MF has bought around 13 Lakh shares during the CORONA panic fall near 1300.  We saw some exits from big past investors during this year.  





Piyush Patel

Piyush Patel

Product Designer
4.75
Loyal User
Expert Vendor
Golden Classes
King Seller
Fantastic Support
Loyal Writer
Profile

Class Sessions

1- Let us Understand the classification of Listed Indian industries _2023 2- Bajaj Auto: CMP: 9852: Long Term Gr: 11% Cy Growth: 19% | Q2_FY_25 RESULTS UPDATE 3- Eicher Motors: CMP: 2546: Long Term Gr: 15 C Year: 141 4- WONDERLA: 878 Long Term Gr: 15% | CYear Gr: 13% | Fy_24 Result updated 5- ### Wonderla Q1 FY25 Financial Analysis 6- Wonderla Q2 FY25 Full Analysis 7- Qualified institutions placement of equity share for Wonderla Holidays ???? 8- BEL: CMP: 290: Sales Long term: 11% Q1_FY25: 20% | Q1_FY_25 Result Updated 9- ### Bharat Electronics Limited (BEL) Q1 FY25 Financial Analysis 10- INDUSTRY DASHBOARD 11- Balkrisind: CMP: 2340 LongTerm CAGR: 15% | Cy Gr: (-10%) | Q3_FY_24 RESULT UPDATE 12- Auto Tyres & Rubbers Industry 13- 14- 15- 16- 17- 18- 19- 20- 21- 22- 23- 24- 25- 26- MRF: CMP: 80400: Long term Gr: 10 CY Gr: 70 27- FAIR VALUE OF MRF: 28- Useful Links 29- Q1 FY25 results for Balkrishna Industries Ltd: 30- ### Balkrishna Industries: Consolidated Q2 FY25 & H1 FY25 Financial Analysis 31- AMARA RAJA BATTERIES CMP: 1548 | LONG TERM GR: 15% | Q1_fy25 GR: 17% | Q1_fy25 Result Update 32- ### Amara Raja Batteries: Consolidated Financial Results for Q1 FY25 33- Asset Management Companies: Industry DASHBOARD 34- HDFC AMC: CMP: 4604 Sales Gr: Long term: 11% | H1_FY25: 37% Result Update 35- Airlines Industry 36- InterGlobe Aviation: CMP: 4270: SALES GR LT: 20% | FY24: 25% RESULT UPDATE 37- Agro Chemicals 38- PI Industries Q1 FY25 Key Highlights 39- PI Industry: CMP: 3790 Sales Gr long term: 19% CYear: 18% | fy_24 result update 40- INDUSTRY DATA 41- Breweries & Distilleries: 42- UBL: CMP: 1491 | Long term Gr: 19% | Cyear Gr: 27% | Fy_23 Result update on 23rd June 23 43- Radico: CMP: 454: CY SALES: -13 44- Kajaria Ceramics: CMP: 1319 | Long growth: 17% | C_Year Growth: 5% | 9M_Fy_24 Results Update 45- TCS: 4149: Sales Growth Long Term: 16% | 9M_fy25Sales: 5.2% | 9M_FY25 Result Update 46- ### Tata Elxsi: CMP: 6203: Long Term: Sales 17% | Cy Sales 6.6% |Q3_Fy_25 Result Update 47- INFY:CMP: 1751: Sales Growth: 17 Profits: 21 48- INFY FAIR VALUE 49- LTI: CMP: 3874 : Cy Sales 31 LongTerm Sales: 18 50- LTI FAIRVALUE 51- TRIO OF IT INDUSTRY: DATA STUDY 52- Cement & Cement Products: 53- Ultracemco: CMP: 11105: Long term Sales Gr 13% | H1_fy25: 0% | H1_fy25_Result Update 54- SHREE CEMENTS: CMP: 21163: LONG TERM GR: 15 CY GROWTH: 21 H1_FY23 RESULT UPDATE: 16TH OC 55- Shreecement Intrinsic Value 56- Eagle’s Eye View: Analysis for UltraTech Cement's Q2 FY25: 57- HAVELLS: CMP: 1636 | Long Term: 15% | | Q2_FY25 Sales Gr: 16% | Q2_FY_25 Result Update 58- *Havells India* Limited's Q1 FY25 results: Eagle’s Eye View: 59- Cigarettes, Tobacco Products: 60- FAIR VALUE: ITC 61- Civil construction industry in India: 62- Larsen & Toubro: CMP: 3690: LONG TERM SALES GR: 16 Q1_FY25: 15% | Q1_fy25 Results Update 63- Rites: CMP: 271: Long Term Gr: 8 CYear -25 64- Fairvalue of RITES 65- Q1 FY25 Results Larsen & Toubro (L&T): 66- ### Larsen & Toubro (L&T) Financial & Operational Summary for Q2 FY25 & H1 FY25 67- India Ratings Affirms Larsen & Toubro’s NCDs at ‘IND AAA’/Stable 68- Dmart: CMP: 4183: Long Term Sales: 27% H1_FY25_Sales: 16% |H1_Fy_25 RESULT UPDATE 69- Diversified Commercial Services 70- TEAMLEASE: CMP: 2639 Long Term Growth: 19% CYear Growth: 16% | Q1_FY24 Result Update 7th Sept 71- HINDUNILVR: CMP: 2427 | LONG TERM GR: 10% | CYEAR GR: 3% | Q3_FY_24 RESULT UPDATE 72- PATANJALI: CMP: 1703 CYear Gr:-8%, Long Term Gr: 10% | Q1_Fy25 Result Update 73- Eagle’s Eye View: Patanjali Foods Limited for Q1 FY25: 74- Patanjali's Q2 FY25 financials: 75- Ecommerce Listed Space 76- ZOMATO FAIRVALUE 77- Zomato's latest Q1 FY25 Results: 78- POWERDATA FOR POWER EXCHANGE 79- IEX: CMP: 209: Long term Gr: 15 Cy Gr: 19% | Q1_FY25 Result Update 80- PowerGrid: CMP: 194 Long term gr: 18 Cy Year: -4 81- CDSL: CMP: 1536 : LONG TERM GROWTH:25% CY GROWTH: 72% | Q1_fy25 Result update 82- ### Analysis of IEX Q1 FY25 Financial Results 83- Finance Including NBFC: 84- Bajaj Finance: CMP: 6610: LT SALES GR: 25% | Q1_FY25_GR: 29% |Q1_fy_25 Results Update 85- IRFC: CMP: 174 | LONG TERM GR: 15% | CYEAR GR: 12% | FY_24 RESULT UPDATE 86- IREDA: CMP: 147 Long term Gr: 20% | Cyear Gr: 35% 9M_FY_25 Result Update 87- Recltd :CMP: 139: 88- Financial results of Indian Railway Finance Corporation (IRFC) for Q1 FY25: 89- *Indian Railway Finance Corporation Limited (IRFC) for Q2 FY25:* 90- Relaxo Footwear: CMP: 836 9M_fy_24 Result updated 91- ## Relaxo Footwears Limited Q1 FY25 Results Analysis 92- Fertilizer 93- Coromandel: CMP 789: Sales growth long term: 12 Cyear: 11 94- DataStudy of Coromandel 95- ICICI GI: 1904 Long Term Sales Gr: 14% | H1_FY25 GR: 15% Q2_fy25 Result Update 96- ICICI GI: 1904 Long Term Sales Gr: 14% | H1_FY25 GR: 15% Q2_fy25 Result Update 97- Eagle's Eye View on ICICI Lombard's Q1_fy25 and insights: 98- Titan Ind CMP: 3769: Long term Sales: 19% | Q1_fy25: 23% q1_FY25 Latest result Update 99- Pageind: CMP: 40187: long term Sales: 19 CYear:55 H1 result update 12th Nov 100- DashBoard of Titan & Page 101- ### Titan Company Limited Q1 FY25 Financial Analysis 102- PAGE INDUSTRIES: CMP: 38982 | Long term Gr: 21% | C Year: (-3%) | FY24 Result Update 103- ### Page Industries Q1 FY25 Financial Analysis and Insights 104- TTK PRESTIGE: CMP: 698 | LONG TERM GR: 12% | CYEAR:(-5%) | Q3_FY_24 RESULT 105- Voltas: CMP: 1778: Sales Gr Long Term: 12% | Q1_fy25: 47% 106- Housing finance companies: 107- *Bajaj Housing Finance Limited (BHFL)* : CMP: 130 Long Term Gr: 30% | CY Gr: 24% 108- HDFC: CMP: 2342 Cy Sales: -2 LongTerm Sales: 23 9M Result Update on 24th Feb-22 Low Dem 109- FAIRVALUE HDFC 110- Lal PathLabs Ltd: CMP: 2752 | LONG TERM GR: 15% | CY GR: 10% | FY24 RESULT UPDATE 111- Healthcare Facilities: Long Term Sales: 17 CYear: -6 112- Apollo Hospital: 6504: Sales Gr Long term: 17% | CY: 15% Q3_fy24 Result Update 113- ### **Apollo Hospitals Q1 FY25 Financial Analysis** 114- Holding Companies: 115- Bajaj Finserv: cmp: Intrinsic Value 116- Bajaj Finserv: cmp: 5952: 117- Internet & Catalogue Services Industry 118- Naukri: CMP: 6780: Long Term Growth: 17 CYear: 8% | FY_24 Result Update 119- Highlights for Info Edge (India) Limited's FY24 results and Q4 FY24 120- Iron & steel Interim. Products 121- JSW Steel: CMP:901: Long term growth: 15% | Q1_fy25 Growth: 1.7% Result Updated 122- TataSteel: CMP: 1088 Sales Gr: 5 Profit Gr: 6X 123- INDUSTRY DATA 124- LTTS: CMP: 4966: LONG TERM GR: 15% Q2_FY_25: Gr: 8% Result Update 125- Advertising & Media Industry 126- AFFLE: CMP: 1528: Long term gr: 49% | Cy Growth: 28% | Q1_FY_25 Result Updated 127- Eagle’s Eye view: *L&T Technology Services (LTTS)* Q1 FY25 results: 128- ### Affle (India) Limited Q1 FY25 Analysis 129- Affle (India) Limited's Q2 FY25 130- Let us Understand the classification of Listed Indian industries 131- Life Insurance Industry 132- HDFC LIFE: CMP: 752: Premium GROWTH LT: 18% | Q2_FY25: 12% Result Update 133- SBI LIFE: CMP: 1076: 1.3x increase in number of claims reported from FY21 to Q1-FY22. 134- SBILIFE FAIRVALUE 135- Route Mobile: CMP: 1791 LONG TERM GROWTH 37% | fy_24: 13% Result Update 136- ### Eagle’s Eye View: Route Mobile Q1 FY25 Analysis 137- Non Alcoholic Beverages 138- VBL: CMP: 1004 Long Term Gr: 17 CY Growth: 34 139- Data Study 140- HDFCBANK: CMP: 1766 | Sales LONG TERM: 20% | SALES Q2_FY25: 13 % 141- Yes Bank: cmp: 15: Cy Sales: -31 Profit: 129 142- ### Eagle’s Eye view: HDFC Bank Q1 FY25 Results Analysis 143- Paints: 144- Asian paints: CMP: 2946: Long Term Gr: 16% | CYear: (-2%) | Q1_FY_25 Result Update 145- Kajaria Cera: 1174: Long term sales: 12 CYear Sales: 79 Q1 Result Update on 29th July-2 146- FAIRVALUE OF KAJARIA 147- SFL: 3407 Long Term Sales: 17 CYear: 30 Huge Demand But Inflations Hurt Profits 9M Re 148- SFL FairValue 149- SBIN:CMP: 817 Sales Gr: 15% | CYEAR GR: 26% | fy24 Result Update 150- SUPREMEIND: CMP: 4803 LONG TERM GR: 13% Q2_fy25 GR: (-2%) | RESULTS UPDATE 151- SUPREMEIND: CMP: 4803 LONG TERM GR: 13% Q2_fy25 GR: (-2%) | RESULTS UPDATE 152- ### Supreme Industries Q2 FY25 Financial Analysis 153- Pharmaceuticals: 154- Divis Lab: CMP 3796: Sales Long Term: 19% CYear: (-24%) Q1_Fy_24 Result Update 12/09/23 155- Pfizer: CMP: 4538: Long Term Sales Gr: 6 CYear: 4 156- Abbott India: CMP 16015: Long Term Gr: 15 CY Gr: 5 157- Sun Pharma: cmp 526: Sales: -9 Profits: Loss 158- Aplltd: cmp: 984: Sales Growth: 28Profit Growth: 65 159- Ajanta Pharma: cmp: 1461: 160- DataBase Of Pharma World 161- ### Divi's Laboratories Limited: Q1 FY25 Financial Analysis 162- Britannia: CMP: 4913: LONG TERM GR: 12% | CYEAR GR: 3% | Q3_FY_24 RESULT UPDATE 163- NESTLE INDIA 2776 Long Term Gr: 11% | H1_fy25 RESULT: SALES GR: 2% 164- Maruti: CMP: 12389: Sales LongTerm: 14%, Sales Q1_FY25: 10% | Q1FY25 RESULT UDPATE 165- M&M: CMP: 892 : LONG TERM GR: 12 CYEAR GR: 30 H1 RESULT UPDATE: 9TH NOV-21 166- FAIR VALUE M&M 167- Personal Care Dashboard 168- Godrej Cons: CMP: 759: Long Term Sales Gr: 12 CYear: 11 169- Godrej Consumer FAIR VALUE 170- Marico: Cmp: 528 : Sales Gr: Long Term: 9 Cyear: 10 171- COLGATE: Cmp: 1600: Sales Gr: 3 Profits: 18 172- Dabur: CMP: 503: Sales Gr: LongTerm: 7 Cyear: 14 173- Jubilant Foods: CMP: 687 Long term Gr: 14% | Q1_FY_25 Gr: 45% 174- Jubilant FoodWorks Limited Q1 FY25 Financial Performance Overview 175- Reliance Industries: CMP: 2719 LT Sales: 13% | CY: Sales: 6% | H1_FY_25 RESULT UPDATE 176- ### *Eagle’s Eye view Analysis of Reliance Industries' Latest Consolidated Results for Q1 FY25*: 177- Chairman's statement at the 47th Annual General Meeting (AGM) of Reliance Industries Limited: 178- Godrej Properties: CMP: 3299 Long Term Gr: 12% | Cyear gr: 35% fy24 Result Update 179- TEAMLEASE: CMP: 2244 Long Term Gr: 18% | C_Year Gr: 21% Result update: 30th May_23 180- MAPMYINDIA: CMP: 3069 | LONG TERM GR: 25% | Q1_fy25: 14% | Q1_fy25 Result Update 181- INDUSTRY DATA 182- ### MapmyIndia Q1 FY25 Financial Analysis and Insights 183- ???? Q2 FY25 Results Analysis for MapMyIndia 184- ???? New Update for MapmyIndia (C.E. Info Systems Limited): 16% Plus today 185- Specialty Retail: 186- PVR: 1599: Sales growth LT: 28 CY: 702 9M RESULT UPDATE ON 4TH FEB-22 187- PVR: FAIRVALUE 188- Specialty Chem Industry 189- Pidilitind: CMP: 3013: Long Term Gr: 16% | Current Year: 5% | FY_24 Result Update 190- TATA CONSUMER: CMP: 960 | Long term Gr: 12% , H1Fy25 Gr: 15% 191- ### Tata Consumer Products Limited Q2FY25 Financial Analysis 192- AU Small Finance Bank: CMP: 599: Long term Gr: 34% Cy Gr: 34% | Q3_FY24 Result Update 193- ### AU Small Finance Bank Q1 FY25 Financial Analysis 194- IRCTC: CMP: 918 LONG TERM GR: 18% | Q1_fy25 GR: 12% | RESULTS UDPATE 195- Telecom Services: LT Growth :14 CAGR Cy Year Growth: 21 196- Bharti Airtel: CMP 697: Long Term Sales: 12 CYear: 12 H1 RESULT UPDATED 3RD NOV-21 197- Bharti Airtel: Intrinsic Value 198- Textiles Industry 199- Textiles Industry DataStudy 200- KPR Mill: CMP: 464: Sales Growth: 43 H1 201- VTL: CMP: 830: Sales Growth -21 202- Garware Technical Fibres Ltd: CMP: 2158: CY Sales: -9 203- ### EMS Ltd Q1 FY25 Results Analysis 204- $50 million loan agreement between the Government of India and the Asian Development Bank (ADB) 205- Indias Largest Companeis in 2030: SUPER-21 206- Utilities Non_electric: longterm Gr: 17 CYear -19 Covid Affected Industry 207- Gail: CMP: 143 : long term Gr: 11 CYear: 44 208- IGL: cmp: 537: Long Term: 21 CYear: -32 209- MGL: cmp: 1107: Long Term Gr: 12 CYear: -28 210- FairValue of MGL 211- Indias TOP 3 Companies would be Crossing 1 Lakh Cr Profits during 2025-30. 212- Reliance Ind: Long Term Gr: 15 CAGR 213- TCS: Long Term Gr: 20 CAGR 214- HDFCBank: LongTerh Gr 22 CAGR 215- Nifty-6 Document 216- Nifty-6 DashBoard 217- Biotechnology 218- Biocon: CMP: 360: Long Term Growth of 15 CY Growth 10 9M Result Updated on 27th Jan-22 219- FAIRVALUE of BIOCON 220- Tata Consultancy Services (TCS), detailing their new partnership with Landis+Gyr 221- ZOMATO: CMP: 274 Long Term Growth: 56% Q1_fy25 Growth: 75% Q1_fy25 Result Update 222- ### Divi's Laboratories Limited: Q1 FY25 Financial Analysis 223- Tata Elxsi Technical Chart